International Clinical Trial: Efficacy and Safety of Immunotherapeutic Intervention with Weika(Mycobacterium vaccae) as an Adjunct to Short-Course Regimen for Initial Treatment of Smear-Negative Pulmonary Tuberculosis

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119746) titled 'Efficacy and Safety of Immunotherapeutic Intervention with Weika(Mycobacterium vaccae) as an Adjunct to Short-Course Regimen for Initial Treatment of Smear-Negative Pulmonary Tuberculosis' on March 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Mianzhu People's Hospital

Condition: tuberculosis

Intervention: Experimental group:4-month short-course chemotherapy (2HRZE/2HR) Bovine tuberculosis immunotherapy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2024-12-21

Target Sample Size: Experimental group:30;Control group:30;

Countries of Recruitmen...